Search research articles
Contact Us
Filters
Showing results (51-60 of 232) with videos related to
Page
of 24
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2001
Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d)
E T Silver, D Gong, B Hazes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 11, 2003
Reciprocal transfer of class I MHC allele specificity between activating Ly-49P and Ly-49W receptors by exchange of beta 4-beta 5 loop residues
Brian J Ma, Elizabeth T Silver, Bart Hazes, et al.
Cancer Genetics and Cytogenetics
|
December 1, 1992
Disappearance of a highly unusual clone, 46,XY,del(7)(p12),t(9;22)(q34;q11) in chronic myeloid leukemia after treatment with recombinant interferon and cytosine arabinoside
F Christodoulidou, R T Silver, M J Macera, et al.
Catheterization and Cardiovascular Diagnosis
|
October 1, 1995
Morphologic characteristics of restenotic lesions following coronary interventions: balloon angioplasty versus directional atherectomy: can we speculate about the mechanism of restenosis from morphologic analysis?
J Moreu, M T Silver, I F Palacios, et al.
Blood
|
February 1, 1982
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E
L M Pelus, S Saletan, R T Silver, et al.
Leukemia Research
|
January 1, 1988
Origin of near-haploidy in malignant hematopoietic cells
R S Verma, M J Macera, R T Silver, et al.
Cancer Treatment Reports
|
June 1, 1985
Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens
M W Pasmantier, M Coleman, R T Silver, et al.
Blood
|
January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States
Gregory H Jones, Michael A Carrier, Richard T Silver, et al.
Cancer Genetics and Cytogenetics
|
October 24, 2002
Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia
Martin L Lesser, Gordon W Dewald, Cristina P Sison, et al.
The Journal of Bone and Joint Surgery. British Volume
|
August 3, 2010
The measurement of patellar height: a review of the methods of imaging
C L Phillips, D A T Silver, P J Schranz, et al.
Page
of 24
Search research articles
Search
Showing results (51-60 of 232) with videos related to
Sort By:
Page
of 24
Journal of Immunology (Baltimore, Md. : 1950)
|
February 13, 2001
Ly-49W, an activating receptor of nonobese diabetic mice with close homology to the inhibitory receptor Ly-49G, recognizes H-2D(k) and H-2D(d)
E T Silver, D Gong, B Hazes, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 11, 2003
Reciprocal transfer of class I MHC allele specificity between activating Ly-49P and Ly-49W receptors by exchange of beta 4-beta 5 loop residues
Brian J Ma, Elizabeth T Silver, Bart Hazes, et al.
Cancer Genetics and Cytogenetics
|
December 1, 1992
Disappearance of a highly unusual clone, 46,XY,del(7)(p12),t(9;22)(q34;q11) in chronic myeloid leukemia after treatment with recombinant interferon and cytosine arabinoside
F Christodoulidou, R T Silver, M J Macera, et al.
Catheterization and Cardiovascular Diagnosis
|
October 1, 1995
Morphologic characteristics of restenotic lesions following coronary interventions: balloon angioplasty versus directional atherectomy: can we speculate about the mechanism of restenosis from morphologic analysis?
J Moreu, M T Silver, I F Palacios, et al.
Blood
|
February 1, 1982
Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E
L M Pelus, S Saletan, R T Silver, et al.
Leukemia Research
|
January 1, 1988
Origin of near-haploidy in malignant hematopoietic cells
R S Verma, M J Macera, R T Silver, et al.
Cancer Treatment Reports
|
June 1, 1985
Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens
M W Pasmantier, M Coleman, R T Silver, et al.
Blood
|
January 29, 2016
Strategies that delay or prevent the timely availability of affordable generic drugs in the United States
Gregory H Jones, Michael A Carrier, Richard T Silver, et al.
Cancer Genetics and Cytogenetics
|
October 24, 2002
Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia
Martin L Lesser, Gordon W Dewald, Cristina P Sison, et al.
The Journal of Bone and Joint Surgery. British Volume
|
August 3, 2010
The measurement of patellar height: a review of the methods of imaging
C L Phillips, D A T Silver, P J Schranz, et al.
Page
of 24